AMT-130 and the 75% Slowdown: What Just Changed for Huntington’s Disease—and What Hasn’t
About this episode
The episode discusses the recent developments regarding AMT-130 for Huntington's Disease, including its implications and challenges.
We Have A Voice Radio dives into the AMT-130 news for Huntington’s—what this one-time, brain-delivered gene therapy is, what the reported “75% slowdown” really means, what’s next for approval, and the hard truths on access and cost.
More episodes of WeHaveAVoice
- Positive Eugenics - Should we worry?
- AMT-130 Update: Breaking through the hype
- The Blue Within
- Chair By The Window: A Huntington's Disease Story
- Huntington's Isn't Rare...It's Ignored
- The Endless Scroll – Huntington’s Disease in the Age of Doomscrolling
Explore listener stats, chart rankings, contacts and more on the WeHaveAVoice podcast page.